Literature DB >> 17229902

Influence of long-term administration of lactulose and Saccharomyces boulardii on the colonic generation of phenolic compounds in healthy human subjects.

Vicky De Preter1, Tamara Coopmans, Paul Rutgeerts, Kristin Verbeke.   

Abstract

OBJECTIVE: Proteins are degraded in the colon by bacterial fermentation into potentially toxic metabolites such as phenolic compounds. The aim of the present study was to investigate whether long-term administration of lactulose or Saccharomyces boulardii cells would result in a lower protein degradation. In addition, the influence of a long-term dietary intake on different gastrointestinal parameters was investigated.
METHODS: The effect of long-term intervention of the substrates was evaluated in a randomized, cross-over study in 43 healthy volunteers. At the start of the study and at the end of each 4-week treatment period, urine was collected during 48 h in different fractions and faeces during 72 h. Breath test samples and blood samples were taken to study gastrointestinal parameters.
RESULTS: No influence of long-term administration of both substrates was found on GE, OCTT and serum lipids. A significant decrease in small intestinal permeability was found after long-term dietary intervention with lactulose. Long-term administration of lactulose significantly decreased urinary p-cresol excretion, but did not lower fecal p-cresol excretion. No significant effects were observed after S. boulardii intake.
CONCLUSION: The results obtained in present study have indicated that colonic amino acid fermentation can be reduced by the administration of lactulose as a fermentable carbohydrate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17229902     DOI: 10.1080/07315724.2006.10719570

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  11 in total

1.  Identification of volatile biomarkers of Giardia duodenalis infection in children with persistent diarrhoea.

Authors:  C Ubeda; E Lepe-Balsalobre; C Ariza-Astolfi; J M Ubeda-Ontiveros
Journal:  Parasitol Res       Date:  2019-10-12       Impact factor: 2.289

2.  Metabolic profiling of umbilical cord blood in macrosomia.

Authors:  H Sun; Y C Wang; C C Wang; X X Xu; Y H Wang; H T Yan; X J Yang
Journal:  Int J Obes (Lond)       Date:  2017-11-21       Impact factor: 5.095

Review 3.  Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases.

Authors:  Manoj Kumar; Ravinder Nagpal; Rajesh Kumar; R Hemalatha; Vinod Verma; Ashok Kumar; Chaitali Chakraborty; Birbal Singh; Francesco Marotta; Shalini Jain; Hariom Yadav
Journal:  Exp Diabetes Res       Date:  2012-05-03

Review 4.  Towards microbial fermentation metabolites as markers for health benefits of prebiotics.

Authors:  Kristin A Verbeke; Alan R Boobis; Alessandro Chiodini; Christine A Edwards; Anne Franck; Michiel Kleerebezem; Arjen Nauta; Jeroen Raes; Eric A F van Tol; Kieran M Tuohy
Journal:  Nutr Res Rev       Date:  2015-06       Impact factor: 7.800

Review 5.  Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.

Authors:  Shunsuke Ito; Masayuki Yoshida
Journal:  Toxins (Basel)       Date:  2014-02-20       Impact factor: 4.546

Review 6.  Gut microbiota and cardiovascular disease: opportunities and challenges.

Authors:  Negin Kazemian; Morteza Mahmoudi; Frank Halperin; Joseph C Wu; Sepideh Pakpour
Journal:  Microbiome       Date:  2020-03-14       Impact factor: 14.650

7.  Pre-, pro-, and synbiotics: do they have a role in reducing uremic toxins? A systematic review and meta-analysis.

Authors:  Megan Rossi; Kerenaftali Klein; David W Johnson; Katrina L Campbell
Journal:  Int J Nephrol       Date:  2012-12-19

8.  The effect of lactulose supplementation on fecal microflora of patients with chronic kidney disease; a randomized clinical trial.

Authors:  Hamid Tayebi-Khosroshahi; Afshin Habibzadeh; Bahram Niknafs; Reza Ghotaslou; Fatemeh Yeganeh Sefidan; Morteza Ghojazadeh; Majid Moghaddaszadeh; Sahar Parkhide
Journal:  J Renal Inj Prev       Date:  2016-07-29

Review 9.  Health Effects and Sources of Prebiotic Dietary Fiber.

Authors:  Justin L Carlson; Jennifer M Erickson; Beate B Lloyd; Joanne L Slavin
Journal:  Curr Dev Nutr       Date:  2018-01-29

10.  Establishing What Constitutes a Healthy Human Gut Microbiome: State of the Science, Regulatory Considerations, and Future Directions.

Authors:  Michael I McBurney; Cindy Davis; Claire M Fraser; Barbara O Schneeman; Curtis Huttenhower; Kristin Verbeke; Jens Walter; Marie E Latulippe
Journal:  J Nutr       Date:  2019-11-01       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.